Upregulated Expression of CYBRD1 Predicts Poor Prognosis of Patients with Ovarian Cancer

Figure 7

(a) Survival analysis of patients with OV from EH cohort according to CYBRD1 expression. Kaplan–Meier survival curves of OV patients for OS in CYBRD1^low and CYBRD1^high groups from EH cohort; (b) ROC curves with respect to the CYBRD1 expression, FIGO stage, and histological grade in patients with OV in EH cohort; (c) nomogram for CYBRD1 and other clinical characteristics in EH cohort OV patients, the C-index = 0.7016; (d) calibration analysis of the nomogram for 1-year OS, 3-year OS, and 5-year OS.

(a)

(b)

(c)

(d)